Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,800 | 187,300 | 182,700 | 218,500 | 214,900 |
| Receivables | 1,316,200 | 1,139,500 | 1,130,100 | 1,267,400 | 1,379,800 |
| Inventories | 2,230,500 | 2,250,600 | 1,937,800 | 2,111,300 | 2,083,700 |
| Other current assets | 444,700 | 443,700 | 679,500 | 382,000 | 418,000 |
| TOTAL | $4,142,200 | $4,021,100 | $3,930,100 | $3,979,200 | $4,096,400 |
| Non-Current Assets | |||||
| PPE Net | 1,949,100 | 1,940,700 | 1,708,200 | 1,926,100 | 1,897,300 |
| Investments And Advances | 183,100 | 182,700 | 179,900 | 80,700 | 88,300 |
| Intangibles | 8,460,800 | 8,406,800 | 8,038,700 | 8,251,200 | 8,038,600 |
| Other Non-Current Assets | 273,000 | 165,300 | 811,400 | 318,300 | 367,800 |
| TOTAL | $10,866,000 | $10,695,500 | $10,738,200 | $10,576,300 | $10,392,000 |
| Total Assets | $15,008,200 | $14,716,600 | $14,668,300 | $14,555,500 | $14,488,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200,100 | 100 | 1,700 | 301,000 | 297,600 |
| Accounts payable and accrued liabilities | 460,700 | 458,300 | 469,300 | 422,900 | 413,100 |
| Accrued Expenses | 767,800 | 703,500 | 908,900 | 1,020,800 | 888,600 |
| TOTAL | $2,496,300 | $2,247,700 | $2,515,400 | $2,913,800 | $2,806,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,861,500 | 5,244,200 | 5,034,900 | 5,037,800 | 5,487,200 |
| aiOther Non-Current Liabilities | 1,217,700 | 1,207,500 | 1,239,600 | 1,066,300 | 834,000 |
| TOTAL | $7,390,200 | $7,647,400 | $7,424,900 | $7,216,500 | $7,340,800 |
| Total Liabilities | $9,886,500 | $9,895,100 | $9,940,300 | $10,130,300 | $10,147,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,173 | 152,757 | 152,459 | 151,384 | 150,828 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 733,700 |
| Retained earnings | 6,719,700 | 6,548,800 | 6,496,300 | 6,238,900 | 6,205,600 |
| Other shareholders' equity | 125,900 | 28,600 | 44,000 | 44,400 | 26,400 |
| TOTAL | $5,121,700 | $4,821,500 | $4,728,000 | $4,425,200 | $4,340,800 |
| Total Liabilities And Equity | $15,008,200 | $14,716,600 | $14,668,300 | $14,555,500 | $14,488,400 |